Biphasic Elimination of Tenofovir Diphosphate and Nonlinear Pharmacokinetics of Zidovudine Triphosphate in a Microdosing StudyJIANMENG CHEN; FLEXNER, Charles; LIBERMAN, Rosa G et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 61, Num 5, pp 593-599, issn 1525-4135, 7 p.Article

RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Tenofovir 1% Gel Compared with Oral Tenofovir Disoproxil FumarateANTON, Peter A; CRANSTON, Ross D; CUMBERLAND, William G et al.AIDS research and human retroviruses. 2012, Vol 28, Num 11, pp 1412-1421, issn 0889-2229, 10 p.Article

Bioequivalence of efavirenz /emtricitabine /tenofovir disoproxil fumarate single-tablet regimenMATHIAS, Anita A; HINKLE, John; MENNING, Mark et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 167-173, issn 1525-4135, 7 p.Article

Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-91 37RAMANATHAN, Srinivasan; GONG SHEN; CHENG, Andrew et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 3, pp 274-279, issn 1525-4135, 6 p.Article

Evaluation of the Safety and Effectiveness of Nevirapine Plus Coformulated Tenofovir/Emtricitabine as First-Line Therapy in Routine Clinical PracticeVALLECILLO, Gabriel; DOMINGO, Pere; MALLOLAS, Josep et al.AIDS research and human retroviruses. 2012, Vol 28, Num 2, pp 165-170, issn 0889-2229, 6 p.Article

Tenofovir disoproxil fumarateGRIM, Shellee A; ROMANELLI, Frank.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 849-859, issn 1060-0280, 11 p.Article

Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavirKEARNEY, Brian P; MATHIAS, Anita; MITTAN, Angelique et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 3, pp 278-283, issn 1525-4135, 6 p.Article

Short Communication: Inadequate Vitamin D Exacerbates Parathyroid Hormone Elevations in Tenofovir UsersCHILDS, Kathryn E; FISHMAN, Sarah L; CONSTABLE, Catherine et al.AIDS research and human retroviruses. 2010, Vol 26, Num 8, pp 855-859, issn 0889-2229, 5 p.Article

Urinary β₂-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarateGATANAGA, Hiroyuki; TACHIKAWA, Natsuo; OKA, Shinichi et al.AIDS research and human retroviruses. 2006, Vol 22, Num 8, pp 744-748, issn 0889-2229, 5 p.Article

Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretrovkal-experienced patientsMILLER, Michael D; MARGOT, Nicolas; BIAO LU et al.The Journal of infectious diseases. 2004, Vol 189, Num 5, pp 837-846, issn 0022-1899, 10 p.Article

Changes in the Renal Function After Tenofovir-Containing Antiretroviral Therapy Initiation in a Senegalese Cohort (ANRS 1215)DE BEAUDRAP, Pierre; MOUHAMADOU BAILA DIALLO; DELAPORTE, Eric et al.AIDS research and human retroviruses. 2010, Vol 26, Num 11, pp 1221-1227, issn 0889-2229, 7 p.Article

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients : 144-Week AnalysisARRIBAS, Jose R; POZNIAK, Anton L; TOOLE, John J et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 1, pp 74-78, issn 1525-4135, 5 p.Article

Comparative Outcomes of Tenofovir-Based and Zidovudine-Based Antiretroviral Therapy Regimens in Lusaka, ZambiaCHI, Benjamin H; MWANGO, Albert; STRINGER, Elizabeth M et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 5, pp 475-481, issn 1525-4135, 7 p.Article

Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patientsREY, David; KREBS, Magali; PARTISANI, Marialuisa et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 530-534, issn 1525-4135, 5 p.Article

Treatment Outcomes of Recommended First-Line Antiretroviral Regimens in Resource-Limited ClinicsAMOROSO, Anthony; ETIENNE-MESUBI, Martine; EDOZIEN, Anthony et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 3, pp 314-320, issn 1525-4135, 7 p.Article

Early Clinical and Programmatic Outcomes with Tenofovir-Based Antiretroviral Therapy in ZambiaCHI, Benjamin H; MWANGO, Albert; SHENEBERGER, Robert et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 1, pp 63-70, issn 1525-4135, 8 p.Article

Tenofovir Selectively Regulates Production of Inflammatory Cytokines and Shifts the IL-12/IL-10 Balance in Human Primary CellsMELCHJORSEN, Jesper; RISØR, Michael W; TOLSTRUP, Martin et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 57, Num 4, pp 265-275, issn 1525-4135, 11 p.Article

Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimensHAWKINS, Trevor; VEIKLEY, Wenoah; CLAIRE, Robert L. St. III et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 4, pp 406-411, issn 1525-4135, 6 p.Article

Longitudinal study on mitochondrial effects of didanosine-tenofovir combinationLOPEZ, Sonia; NEGREDO, Eugènia; CLOTET, Bonaventura et al.AIDS research and human retroviruses. 2006, Vol 22, Num 1, pp 33-39, issn 0889-2229, 7 p.Article

Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patientsWIRDEN, Marc; MARCELIN, Anne Genevieve; KATLAMA, Christine et al.Journal of medical virology. 2005, Vol 76, Num 3, pp 297-301, issn 0146-6615, 5 p.Article

Lack of Minority K65R-Resistant Viral Populations Detected After Repeated Treatment Interruptions of Tenofovir/Zidovudine and Lamivudine in a Resource-Limited SettingMCCORMICK, Adele L; GOODALL, Ruth L; JOYCE, Aengus et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 2, pp 215-217, issn 1525-4135, 3 p.Article

Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehydeSPARIDANS, Rolf W; CROMMENTUYN, Kristel M. L; SCHELLENS, Jan H. M et al.Journal of chromatography. B. 2003, Vol 791, Num 1-2, pp 227-233, issn 1570-0232, 7 p.Article

Association between ABCC2 Gene Haplotypes and Tenofovir-Induced Proximal Tubulopathy. CommentaryHULGAN, Todd; HAAS, David W; DERAY, Gilbert et al.The Journal of infectious diseases. 2006, Vol 194, Num 11, issn 0022-1899, 1471-1474,1481-1491 [15 p.]Article

Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected childrenHAZRA, Rohan; BALIS, Frank M; LIJIE ZHONG et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 124-129, issn 0066-4804, 6 p.Article

Short Communication: Early Changes in Parathyroid Hormone Concentrations in HIV-Infected Patients Initiating Antiretroviral Therapy with TenofovirMASIA, Mar; PADILLA, Sergio; ROBLEDANO, Catalina et al.AIDS research and human retroviruses. 2012, Vol 28, Num 3, pp 242-246, issn 0889-2229, 5 p.Article